Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea, et al.
New England Journal of Medicine (2013) Vol. 368, Iss. 19, pp. 1781-1790
Open Access | Times Cited: 541

Showing 1-25 of 541 citing articles:

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2391-2405
Open Access | Times Cited: 9112
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal, et al.
Blood (2015) Vol. 126, Iss. 1, pp. 9-16
Open Access | Times Cited: 1720
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Nature Genetics (2016) Vol. 49, Iss. 2, pp. 204-212
Open Access | Times Cited: 382
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
Raajit K. Rampal, Fátima Al‐Shahrour, Omar Abdel‐Wahab, et al.
Blood (2014) Vol. 123, Iss. 22, pp. e123-e133
Open Access | Times Cited: 379
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
G-CSF and GM-CSF in Neutropenia
Hrishikesh Mehta, Michael Malandra, Seth J. Corey
The Journal of Immunology (2015) Vol. 195, Iss. 4, pp. 1341-1349
Open Access | Times Cited: 318
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena, Anna Gallí, Esperanza Such, et al.
Blood (2016) Vol. 128, Iss. 10, pp. 1408-1417
Open Access | Times Cited: 300
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
Animesh Pardanani, Terra L. Lasho, Rebecca R. Laborde, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1870-1873
Open Access | Times Cited: 247
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
Ayalew Tefferi, J. Thiele, Alessandro M. Vannucchi, et al.
Leukemia (2014) Vol. 28, Iss. 7, pp. 1407-1413
Open Access | Times Cited: 214
Diagnosis and classification of hematologic malignancies on the basis of genetics
Justin Taylor, Wenbin Xiao, Omar Abdel‐Wahab
Blood (2017) Vol. 130, Iss. 4, pp. 410-423
Open Access | Times Cited: 212
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox, et al.
Blood (2014) Vol. 123, Iss. 17, pp. 2645-2651
Open Access | Times Cited: 201
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Lynn Quek, Muriel D. David, Alison Kennedy, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1167-1177
Open Access | Times Cited: 178
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Yusuke Shiozawa, Luca Malcovati, Anna Gallí, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 165
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo, Manja Meggendorfer, Stephan Hütter, et al.
Blood (2020) Vol. 136, Iss. 16, pp. 1851-1862
Open Access | Times Cited: 151
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 143
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment
Jason Gotlib, Julia E. Maxson, Tracy I. George, et al.
Blood (2013) Vol. 122, Iss. 10, pp. 1707-1711
Open Access | Times Cited: 181
Disease evolution and outcomes in familial AML with germline CEBPA mutations
Kiran Tawana, Jun Wang, Aline Renneville, et al.
Blood (2015) Vol. 126, Iss. 10, pp. 1214-1223
Open Access | Times Cited: 178
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Michael R. Savona, Luca Malcovati, Rami S. Komrokji, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1857-1865
Open Access | Times Cited: 172
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders
William Vainchenker, Emilie Leroy, Laure Gilles, et al.
F1000Research (2018) Vol. 7, pp. 82-82
Open Access | Times Cited: 142
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
M. Cazzola
Blood (2016) Vol. 127, Iss. 20, pp. 2361-2364
Open Access | Times Cited: 140
Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies
Pankaj Dwivedi, Kenneth D. Greis
Experimental Hematology (2016) Vol. 46, pp. 9-20
Open Access | Times Cited: 134
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
Carlo Gambacorti‐Passerini, Carla Donadoni, Andrea Parmiani, et al.
Blood (2014) Vol. 125, Iss. 3, pp. 499-503
Open Access | Times Cited: 128
Page 1 - Next Page

Scroll to top